The treatment of female stress urinary incontinence: An evidenced-based review

Open Access Journal of Urology

Volumn 3, Issue 1, 2011, Pages 109-120

  Cameron, Anne P ^a   Haraway, Allen McNeil ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Conservative and surgical treatment; Stress urinary incontinence

Indexed keywords

BULKING AGENT; COAPTITE; COLLAGEN; DIMETICONE; DULOXETINE; DURASPHERE; FAT; GLUTARALDEHYDE CROSS LINKED COLLAGEN; HYDROXYAPATITE; MACROPLASTIQUE; PERMACOL; PLACEBO; SODIUM CHLORIDE; UNCLASSIFIED DRUG; URETHRAL BULKING AGENT; URYX; ZIRCONIUM OXIDE; ZUIDEX;

BLADDER NECK NEEDLE SUSPENSION; BLADDER SPHINCTER PROSTHESIS; BLADDER SURGERY; CLINICAL EFFECTIVENESS; COLPOSUSPENSION; COMPUTER AIDED DESIGN; CONSERVATIVE TREATMENT; DRUG EFFICACY; DRUG THERAPY; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRINSIC SPHINCTER DEFICIENCY; KELLY PLICATION; LAPAROSCOPIC SURGERY; MEDICAL LITERATURE; META ANALYSIS (TOPIC); MICTURITION DISORDER; MINI SLING; OPEN ABDOMINAL RETROPUBIC SUSPENSION; OUTCOME ASSESSMENT; PELVIC FLOOR MUSCLE TRAINING; PUBOVAGINAL SLING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL TRANSPLANTATION; STRESS INCONTINENCE; SUBURETHRAL SLING; SYSTEMATIC REVIEW (TOPIC); TENSION FREE VAGINAL TAPE; TRANSOBTURATOR TAPE; UNSPECIFIED SIDE EFFECT; URETHRA DISEASE; URINE RETENTION; WEIGHT REDUCTION;

EID: 84930480096     PISSN: None     EISSN: 11791551     Source Type: Journal    
DOI: 10.2147/OAJU.S10541     Document Type: Review

References (72)

1. Haylen BT, de Ridder D, Freeman RM, et al. An International UrogynecologicalAssociation (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4-20.
2. Berghmans L, Hendriks H. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol. 1998;82:181-191.
3. Rapp D, Kobashi K. Outcomes following sling surgery: importance of definition of success. J Urol. 2008;180:998-1002.
4. Wilson P. Adult Conservative Management. Health Publications. 2005;11:869-883.
5. Gormely E. Biofeedback and behavioral therapy for the management of stress urinary incontinence. Urol Clin North Am. 2002;29:551-557.
6. Subak L, Wing R, West D, Franklin F. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360:481-490.
7. Wing R, Smith D, Grady D, Creasman J, Richter H, Myers D. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol. 2010;184:1005-1010.
8. Subak L, Richter H, Hunskaar S. Obesity and urinary incontinence: epidemiology and clinical research update. J Urol. 2009;182:S2-S7.
9. Cannon T, Chancellor M. Pharmacotherapy for stress urinary incontinence. Rev Urol. 2003;5:135-141.
10. Thor K, Katofiasc M. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther. 1995;274:1014.
11. Dmochowski R, Miklos J, Norton P, Zinner N, Yalcin I, Bump R. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol. 2003;170:1259-1263.
12. Millard R, Moore K, Rencken R, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence: A four continent randomized clinical trial. Br J Urol Int. 2004;93:311-318.
13. Corcos J, Collet JP, Shapiro S, et al. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology. 2005;65:898-904.
14. Klarskov N, Lose G. Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn. 2008;27:789-792.
15. Bent AE, Foote J, Siegel S, Faerber G, Chao R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol. 2001;166:1354-1357.
16. TerMeulen PH, Berghmans LC, Nieman FH, van Kerrebroeck PE. Effects of Macroplastique implantation system for stress urinary incontinence and urethral hypermobility in women. Int Urogynecol J Pelvic Floor Dysfunct. 2009;2:177-183.
17. Maher CF, O'Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG. 2005;112:797-801.
18. Malizia AA Jr, Reiman HM, Myers RP, et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA. 1984;251:3277-3281.
19. Dmochowski R, Herschorn S, Corcos J. Multicenter randomized controlled study to evaluate Uryx® urethral bulking agents in treating female stress urinary incontinence. Proceedings International Continence Society (ICS) 2002 (Heidelberg, Germany):187.
20. Kumar D, Kaufman M, Dmochowski R. Case reports: Periurethral bulking agents and presumed urethral diverticula. Int Urogynecol J Pelvic Floor Dysfunction. 2011. [Epub ahead of print].
21. Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:869-873.
22. Lightner DJ, Fox J, Klingele C. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Urology. 2010;75:1310-1314.
23. Lightner D, Rovner E, Corcos J, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigencystoscopically. Urology. 2009;4:771-775.
24. Strasser H, Marksteiner R, Margreiter E, et al. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomized controlled trial. Lancet. 2007;369:2179-2186.
25. Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized doubleblind controlled trial. J Urol. 2001;1:153-158.
26. Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2007;3:CD003881.
27. Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J Urol. 2009;181:204-210.
28. Mayer RD, Dmochowski RR, Appell RA, et al. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007;69:876-880.
29. Andersen RC. Long-term follow-up comparison of durasphere and contigen in the treatment of stress urinary incontinence. J Low Genit Tract Dis. 2002;6:239-243.
30. Koduri S, Goldberg RP, Kwon C, Dobrez DG, Sand PK. Factors influencing the long-term success of periurethral collagen therapy in the office. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:346-351.
31. Isom-Batz G, Zimmern PE. Collagen injection for female urinary incontinence after urethral or periurethral surgery. J Urol. 2009;181:701-704.
32. Lai HH, Hurtado EA, Appell RA. Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1315-1317.
33. Palma PC, Riccetto CL, Martins MH, et al. Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:670-671.
34. terMeulen PH, Berghmans LC, van Kerrebroeck PE. Systematic review: efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol. 2003;44:573-582.
35. Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. J Urol. 2010;183:1444-1449.
36. Bano F, Barrington JW, Dyer R. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:147-150. discussion 150.
37. Lightner D, Calvosa C, Andersen R, et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology. 2001;58:12-15.
38. Appell RA, Dmochowski RR, Herschorn S. Urethral injections for female stress incontinence. BJU Int. 2006;98(Suppl 1):27-30. discussion 31.
39. Pannek J, Brands FH, Senge T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol. 2001;166:1350-1353.
40. Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol. 2006;175:1408-1410.
41. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:881-883.
42. Rapp DE, Kobashi KC. Outcomes following sling surgery: importance of definition of success. J Urol. 2008;180:998-1002.
43. Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;24(356):2143-2155.
44. Ward K, Hilton P. United Kingdom and Ireland Tension-free Vaginal Tape Trial Group. Prospective multicentrerandomised trial of tensionfree vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ. 2002;13(325):67.
45. Chartier-Kastler E, Van Kerrebroeck P, Olianas R, et al. Artificial urinary sphincter (AMS 800) implantation for women with intrinsic sphincter deficiency: a technique for insiders? BJU Int. 2011;107:1618-1626.
46. Glazener CM, Cooper K. Anterior vaginal repair for urinary incontinence in women. Cochrane Database Syst Rev. 2001;1: CD001755.
47. Glazener CM, Cooper K. Bladder neck needle suspension for urinary incontinence in women. Cochrane Database Syst Rev. 2004;2:CD003636.
48. Dean NM, Ellis G, Wilson PD, Herbison GP. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2006;3:CD002239.
49. Lapitan MC, Cody JD, Grant A. Open retropubiccolposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2009;2:CD002912.
50. Demirci F, Yucel O. Comparison of pubovaginal sling and burchcolposuspension procedures in type I/II genuine stress incontinence. Arch Gynecol Obstet. 2001;265:190-194.
51. Nager CW, FitzGerald M, Kraus SR, et al. Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women. J Urol. 2008;179:1470-1474.
52. Kenton K, Richter H, Litman H, et al. Risk factors associated with urge incontinence after continence surgery. J Urol. 2009;182:2805-2809.
53. Brubaker L, Chiang S, Zyczynski H, et al. The impact of stress incontinence surgery on female sexual function. Am J Obstet Gynecol. 2009;200:562.e1-562.e7.
54. Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2010;58:218-238.
55. Brubaker L, Cundiff G, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354:1557-1566.
56. Rehman H, Bezerra CC, Bruschini H, Cody JD. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2011;1:CD001754.
57. Guerrero KL, Emery SJ, Wareham K, Ismail S, Watkins A, Lucas MG. A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG. 2010;117:1493-1502.
58. Ozog Y, Konstantinovic M, Zheng F, et al. Porous acellular porcine dermal collagen implants to repair fascial defects in a rat model: biomechanical evaluation up to 180 days. Gyneco l Obstet Invest. 2009;68:205-212.
59. Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Sys Rev. 2009;4:CD006375.
60. Petros P, Ulmsten U. An integral theory of female urinary incontinence: experimental and clinical considerations. Acta Obstet Gynecol Scand. 1997;166:3-8.
61. Delorme E. Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol. 2001;11:1306-1313.
62. DeLeval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol. 2003;44:724-730.
63. Liapis A, Bakas P, Creatsas G. Monarc vs. TVT-O for the treatment of primary stress incontinence: a randomized study. Int Urogynecol J Pelvic Floor Dysfunction. 2008;19:185-190.
64. Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali H. Evaluation of transobturator tapes (E-TOT) study: randomized prospective singleblinded study comparing inside-out vsoutside-in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. Eur J Obstet Gynecol Reprod Biol. 2010;149:106-111.
65. But I, Faganelji M. Complications and short term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:857-861.
66. Takeyama M, Fukumoto Y, Noma M, Yamamoto K, Yamanaka M, Uesaka Y. A prospective study about trans-obturator tape procedures with the tape from the Gynecare TVT device and a C-shaped tunneling device. Available at: http://www.urotoday.com. Accessed June 1, 2010.
67. Latthe P, Foon R, Toozs-Hobson P. Transobturator and Retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG. 2007;114:522-531.
68. Sung V, Schleinitz M, Rardin C, Ward R, Myers D. Comparison of retropubic vs transobturator approach to midurethral slings: a systematic review and meta-analysis. Am J Obstet Gynecol. 2009;21:342-347.68.
69. Araco F, Gravante G, Sorge R, et al. TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. Int Urogynecol J. 2008;19:917-926.
70. Richter H, Albo M, Zyczynski H, et al. Retropubic versus transobturatormidurethral slings for stress incontinence. N Engl JMed. 2010;362:2066-2076.
71. Schierlitz L, Dwyer L, Rosamilia A, et al. Effectiveness of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstet Gynecol. 2008;112:1253-1261.
72. Kennelly M, Moore R, Nguyen J, Lukban J, Siegel S. Prospective evaluation of a single incision sling for stress urinary incontinence. J Urol. 2010;184:604-609.